Publications directory

Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm

The web Directory of Information Materials for People Affected by Cancer is regularly updated and currently has details of over 1,900 booklets, leaflets, books and audiovisual materials for people affected by cancer. Most have been published in the last five years but we have included some older ones that are still useful.

Results: 246

Cover image of 'FEC-T chemotherapy [Romanian]'

FEC-T chemotherapy [Romanian] (September 2017)

Macmillan Cancer Support

This information describes the FEC-T chemotherapy regimen, which is used to treat breast cancer. It describes the drugs used, how treatment is given, and some of the possible side-effects.

Cover image of 'EC chemotherapy [Latvian]'

EC chemotherapy [Latvian] (2017)

Macmillan Cancer Support

The EC chemotherapy regime (epirubicin and cyclophosphamide) is used to treat breast cancer. This factsheet describes how this combination is given and the possible side-effects.

Cover image of 'Vinorelbine and cisplatin chemotherapy [Chinese, Traditional]'

Vinorelbine and cisplatin chemotherapy [Chinese, Traditional] (November 2017)

Macmillan Cancer Support

Vinorelbine and cisplatin may be used to treat non-small-cell lung cancer. This factsheet describes what it is, how the drugs are given and the possible side-effects.

Cover image of 'BEAM chemotherapy [Punjabi]'

BEAM chemotherapy [Punjabi] (November 2017)

Macmillan Cancer Support

This information from the Macmillan Cancer Support website has been translated into Punjabi. BEAM is a combination chemotherapy treatment used to treat Hodgkin lymphoma and non-Hodgkin lymphoma. It is given before a stem cell transplant. It may also be used to treat other cancers. This factsheet describes what it is, how it is given, and possible side effects.

Cover image of 'FOLFIRINOX'

FOLFIRINOX (May 2017)

Pancreatic Cancer UK

FOLFIRINOX is a possible treatment option for advanced pancreatic cancer. It is a combination of four drugs (leucovorin (folinic acid), fluorouracil, irinotecan and oxaliplatin). This factsheet describes how it is given and the possible side effects.

Cover image of 'DT-PACE'

DT-PACE (November 2017)

Myeloma UK

DT-PACE is a treatment combination used to treat myeloma patients who have received several previous treatments or who are refractory to treatment. This factsheet describes what it is, how it works, how it is given, and possible side-effects.

Cover image of 'Prostate cancer information booklet'

Prostate cancer information booklet (January 2020)

PCaSO Prostate Cancer Support Network

This booklet covers diagnosis (including the DRE and the PSA test), the Gleason score and the staging of prostate cancer, treatment options (active surveillance, watchful waiting, radical prostatectomy, external beam radiotherapy, brachytherapy, cryotherapy, high intensity focused ultrasound, hormone treatment, chemotherapy and photodynamic therapy), clinical trials, side effects (sexual problems, continence, bone health), and diet and lifestyle.

Cover image of 'Capecitabine (Xeloda®) [Polish]'

Capecitabine (Xeloda®) [Polish] (January 2020)

Macmillan Cancer Support

Capecitabine is given as a treatment for many types of cancer including colorectal cancer, breast cancer, oesophageal cancer, pancreatic cancer and stomach cancer. This factsheet describes how it is given and some of the possible side-effects.

Cover image of 'Hydroxycarbamide (Hydrea®) [Bulgarian]'

Hydroxycarbamide (Hydrea®) [Bulgarian] (2020)

Macmillan Cancer Support

Hydroxycarbamide (also known as hydroxyurea) is used to treat chronic myeloid leukaemia, cervical cancer, and some pre-cancerous conditions. This factsheet describes how it is given and the possible side-effects.

Cover image of 'Docetaxel (Taxotere)'

Docetaxel (Taxotere) (October 2020)

Breast Cancer Now

This factsheet explains briefly what Taxotere® is, when it may be prescribed, how it works, the benefits, and possible side-effects.

Sorry, no publications found.
Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm